InsidersTradesSigma
신흥 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 신흥 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 신흥 has logged 145 public disclosures. Market capitalisation: €130.1bn. The latest transaction was filed on 29 May 2026 (Purchase). Among the most active insiders: 이용익. Every trade is free.
141
Insider Decl.
n/a
Thresholds
€639,089
22 ops.
Buy Volume
€397,056
48 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,265 of 28,065 companies
42.2
score / 100
Value38
Quality46
FCF yld-1.2%
Earn yld2.2%
EV/EBITDA15.2x
ROE3.0%
Gross mgn31%
Net mgn2.8%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 May 2026
Declarations145 total
Other
Other(filed)
Other
Other(filed)
Other
Other(filed)
Other
Other(filed)
25 of 145 declarations
About 신흥
신흥 is a company in the healthcare and pharmaceutical sector listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.